Acasti Pharma Stock Forecast, Price & News

Acasti Pharma (CVE:ACST) Frequently Asked Questions

What stocks does MarketBeat like better than Acasti Pharma?

Wall Street analysts have given Acasti Pharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Acasti Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Acasti Pharma's next earnings date?

Acasti Pharma is scheduled to release its next quarterly earnings announcement on Monday, November 15th 2021.
View our earnings forecast for Acasti Pharma.

How has Acasti Pharma's stock price been impacted by COVID-19?

Acasti Pharma's stock was trading at C$0.54 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ACST stock has increased by 325.9% and is now trading at C$2.30.
View which stocks have been most impacted by COVID-19.

Who are Acasti Pharma's key executives?

Acasti Pharma's management team includes the following people:

• Ms. Janelle D'Alvise, Pres, CEO, Corp. Sec. & Director (Age 65, Pay $428.04k)
• Dr. Pierre Lemieux, Co-Founder, COO & Chief Scientific Officer (Age 56, Pay $276.38k)
• Mr. Brian D. Ford CPA, CA, Chief Financial Officer (Age 62, Pay $364.82k)

Who are some of Acasti Pharma's key competitors?

Some companies that are related to Acasti Pharma include Synairgen (SNG), ProMetic Life Sciences (PLI), Horizon Discovery Group plc (HZD.L) (HZD), Fennec Pharmaceuticals (FRX), VIVO Cannabis (ABCN), Emblem (EMC), Aptose Biosciences (APS), Redx Pharma (REDX), Verona Pharma plc (VRP.L) (VRP), Agronomics (ANIC), Burcon NutraScience (BU), Bioventix (BVXP), e-therapeutics (ETX), Circassia Group (CIR) and Arix Bioscience (ARIX).
View all of ACST's competitors.

What other stocks do shareholders of Acasti Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acasti Pharma investors own include Matinas BioPharma (MTNB), Aurora Cannabis (ACB), SCYNEXIS (SCYX), Square (SQ), Nokia (NOK), Axsome Therapeutics (AXSM), Blink Charging (BLNK), Inovio Pharmaceuticals (INO), Okta (OKTA) and Tesla (TSLA).

What is Acasti Pharma's stock symbol?

Acasti Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ACST."

How do I buy shares of Acasti Pharma?

Shares of ACST and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Acasti Pharma's stock price today?

One share of ACST stock can currently be purchased for approximately C$2.30.

How much money does Acasti Pharma make?

Acasti Pharma has a market capitalization of C$101.86 million and generates C$196,000.00 in revenue each year.

How many employees does Acasti Pharma have?

Acasti Pharma employs 32 workers across the globe.

What is Acasti Pharma's official website?

The official website for Acasti Pharma is www.acastipharma.com.

Where are Acasti Pharma's headquarters?

Acasti Pharma is headquartered at 545 Prom du Centropolis Suite 100, LAVAL, QC H7T 0A3, Canada.

How can I contact Acasti Pharma?

Acasti Pharma's mailing address is 545 Prom du Centropolis Suite 100, LAVAL, QC H7T 0A3, Canada. The company can be reached via phone at +1-450-6864555.